← SynDRA
LOREDIPLON
SynDRA canonical compound SYN0039851 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | GABRA1 |
|---|
| Mechanism of action | GABA receptor modulator |
|---|
All known targets
- GABRA1
- GABRA2
- GABRA3
- GABRA4
- GABRA5
- GABRA6
- GABRB1
- GABRB2
- GABRB3
- GABRD
- GABRE
- GABRG1
Mechanisms of action (all sources)
- GABRA1 POSITIVE ALLOSTERIC MODULATOR
- GABRB2 POSITIVE ALLOSTERIC MODULATOR
- GABRG2 POSITIVE ALLOSTERIC MODULATOR
- GABRB3 POSITIVE ALLOSTERIC MODULATOR
- GABRA4 POSITIVE ALLOSTERIC MODULATOR
- GABRG3 POSITIVE ALLOSTERIC MODULATOR
- GABRQ POSITIVE ALLOSTERIC MODULATOR
- GABRA3 POSITIVE ALLOSTERIC MODULATOR
- GABRP POSITIVE ALLOSTERIC MODULATOR
- GABRD POSITIVE ALLOSTERIC MODULATOR
- GABRG1 POSITIVE ALLOSTERIC MODULATOR
- GABRB1 POSITIVE ALLOSTERIC MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- Gf-015535-00
- VKU6Z23NSY
- lorediplonum
- RefChem:154102
- DTXCID50161175
- Lorediplon [INN]
- GF-015535-00
- UNII-VKU6Z23NSY
- Lorediplon?
- MFCD27987938
- LOREDIPLON [WHO-DD]
- orb1296263
- SCHEMBL1316601
- SCHEMBL29376531
- NQPOCLFSADOXBR-UHFFFAOYSA-N
- GLXC-90336
- EX-A4221
- AKOS030526996
- CS-5271
- SB16784
- AC-35359
- AS-56211
- DA-65056
- HY-19371
- A12937
- F828661
- BRD-K42066335-001-01-0
Look up LOREDIPLON in the interactive SynDRA portal →